Shadowfax IPO is in focus as investors track the latest grey market premium (GMP) and assess 10 key factors, including valuation, growth prospects and risks, ahead of the issue’s subscription window.
Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth
Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by robust growth in its CDMO